Antibiotic use and overall survival in lung cancer patients receiving nivolumab.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: antibiotic use, nivolumab, lung cancer, overall survival, immune checkpoint inhibitors, gut microbiota, immunotherapy resistance, immune-related adverse events, antibiotic-associated infection, immune-related pneumonitis, immune-related colitis, immune-related endocrinopathy, immune-related hepatitis, immune-related encephalitis, immune-related hypophysitis
Open Access status: closed
OpenAlex ID: W2891534248
